Stratec (ETR:SBS) Given a €74.00 Price Target at Deutsche Bank

Deutsche Bank set a €74.00 ($86.05) target price on Stratec (ETR:SBS) in a report released on Friday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

SBS has been the subject of a number of other reports. Berenberg Bank set a €71.00 ($82.56) price objective on shares of Stratec and gave the stock a buy rating in a report on Thursday, August 22nd. Warburg Research set a €66.00 ($76.74) price objective on shares of Stratec and gave the stock a neutral rating in a report on Monday, October 21st.

Shares of SBS opened at €66.50 ($77.33) on Friday. The firm has a market cap of $798.52 million and a price-to-earnings ratio of 76.88. The company has a debt-to-equity ratio of 59.01, a quick ratio of 1.59 and a current ratio of 2.93. Stratec has a fifty-two week low of €49.00 ($56.98) and a fifty-two week high of €77.60 ($90.23). The firm has a 50 day moving average price of €70.95 and a 200-day moving average price of €63.70.

About Stratec

Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers.

Featured Story: Conference Calls and Individual Investors

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.